BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22211663)

  • 1. Implications of RNA helicases in HIV-1 replication: possible roles in latency.
    Ajamian L; Mouland AJ
    Curr HIV Res; 2011 Dec; 9(8):588-94. PubMed ID: 22211663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.
    Khanal S; Schank M; El Gazzar M; Moorman JP; Yao ZQ
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV reservoirs and the possibility of a cure for HIV infection.
    Palmer S; Josefsson L; Coffin JM
    J Intern Med; 2011 Dec; 270(6):550-60. PubMed ID: 21929712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unified concept of HIV latency.
    Bagasra O
    Expert Opin Biol Ther; 2006 Nov; 6(11):1135-49. PubMed ID: 17049012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attacking the HIV reservoir from the immune and viral perspective.
    Massanella M; Martinez-Picado J; Blanco J
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):33-41. PubMed ID: 23242702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
    Persaud D; Ray SC; Kajdas J; Ahonkhai A; Siberry GK; Ferguson K; Ziemniak C; Quinn TC; Casazza JP; Zeichner S; Gange SJ; Watson DC
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):381-90. PubMed ID: 17411371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
    Saksena NK; Potter SJ
    AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we need to do to cure HIV infection.
    Siliciano RF
    Top HIV Med; 2010; 18(3):104-8. PubMed ID: 20921575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003.
    Tossing G
    Eur J Med Res; 2004 Feb; 9(2):83-6. PubMed ID: 15090294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.
    Pomerantz RJ
    HIV Clin Trials; 2003; 4(2):137-43. PubMed ID: 12671782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary mechanisms of retroviral persistence.
    Whitney JB; Lim SY; Wainberg MA
    AIDS Rev; 2011; 13(4):234-9. PubMed ID: 21975359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular basis of HIV-1 latency - Part II: HIV-1 reactivation and therapeutic implications].
    Cherrier T; Le Douce V; Redel L; Marban C; Aunis D; Rohr O; Schwartz C
    Med Sci (Paris); 2010 Mar; 26(3):291-5. PubMed ID: 20346279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers for HIV Cure: The Latent Reservoir.
    Castro-Gonzalez S; Colomer-Lluch M; Serra-Moreno R
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):739-759. PubMed ID: 30056745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
    Chun TW; Engel D; Berrey MM; Shea T; Corey L; Fauci AS
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8869-73. PubMed ID: 9671771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.
    Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.